MedixMAB™ Antibodies & MedixAntigens™

Most recent

IVD market trends in Covid-19 pandemic

September 28, 2020

We now offer more with combined product portfolios

September 14, 2020

Wide reagent range for COVID-19 assay development

July 15, 2020

Discover the newest MedixMAB™ Products

June 30, 2020

Medix Biochemica Organizational Update

June 24, 2020

21 Aug

CACLP 2020

Booth A3-T29

Nanchang, China

Medix Biochemica broadens product portfolio and further expands U.S. presence through acquisition of EastCoast Bio

June 5, 2020

Medix Biochemica expands to Drugs of Abuse antibody and antigen manufacturing through acquisition of Biostride Inc.

June 5, 2020

More SARS-CoV-2 antibodies and antigens

May 18, 2020

Expanding Covid-19 diagnostics product portfolio

April 28, 2020

Partner with us in the fight against COVID-19 outbreak

March 27, 2020

Introducing Steve Ferguson, Medix Biochemica’s new CEO

March 20, 2020